You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

unresectable or metastatic GIST

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastrointestinal Stromal Tumor (GIST), Digestive System Disease, Gastrointestinal Diseases Trial in Boston (IDRX-42)

Recruiting
  • Gastrointestinal Stromal Tumor (GIST)
  • +3 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Aug 16, 2022

Gastrointestinal Stromal Tumors, GIST Trial (Avapritinib, midazolam)

Not yet recruiting
  • Gastrointestinal Stromal Tumors
  • GIST
  • (no location specified)
Jul 20, 2022

Unresectable Gastrointestinal Stromal Tumor (GIST), Locally Advanced Gastrointestinal Stromal Tumor (GIST), Metastatic

Recruiting
  • Unresectable Gastrointestinal Stromal Tumor (GIST)
  • +2 more
  • Atezolizumab 1200 mg
  • Imatinib 400 MG
  • Lyon, Rhône, France
  • +4 more
Apr 28, 2022

Liver Diseases, Liver Cancer, Liver Metastases Trial in Murcia (Liver Transplantation)

Not yet recruiting
  • Liver Diseases
  • +27 more
  • Liver Transplantation
  • Murcia, Spain
    Felipe Alconchel
Feb 24, 2022

Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations

Not yet recruiting
  • Gastrointestinal Stromal Tumors
  • +2 more
    • (no location specified)
    Jul 15, 2022

    Gastrointestinal Stromal Tumors Trial in Seoul (PDR001, Imatinib)

    Recruiting
    • Gastrointestinal Stromal Tumors
    • PDR001, Imatinib
    • Seoul, Korea, Republic of
      Asan Medical Center
    Jun 22, 2021

    Gastrointestinal Stromal Tumor Trial in Los Angeles (Ipilimumab, Laboratory Biomarker Analysis, Nivolumab)

    Completed
    • Gastrointestinal Stromal Tumor
    • Ipilimumab
    • +2 more
    • Los Angeles, California
      Rachel Andes
    Aug 15, 2022

    Gastrointestinal Stromal Tumors Trial in Seoul (imatinib)

    Active, not recruiting
    • Gastrointestinal Stromal Tumors
    • Seoul, Korea, Republic of
      Asan Medical Center, University of Ulsan College of Medicine
    Jun 22, 2021

    Stomach Cancer, Gastric (Stomach) Cancer, Tumor of Cardioesophageal Junction Trial in Stanford (bevacizumab, carboplatin,

    Completed
    Has Results
    • Stomach Cancer
    • +3 more
    • Stanford, California
      Stanford University School of Medicine
    Jun 29, 2021

    GIST Trial in Worldwide (avapritinib, regorafenib)

    Completed
    Has Results
    • GIST
    • Phoenix, Arizona
    • +113 more
    Sep 9, 2022

    GIST Trial (Avapritinib)

    Approved for marketing
    • GIST
    • (no location specified)
    Jul 23, 2020

    Gastrointestinal Stromal Tumors Trial in Seoul (Paclitaxel)

    Recruiting
    • Gastrointestinal Stromal Tumors
    • Seoul, Korea, Republic of
      Asan Medical Center
    Dec 30, 2022

    Unresectable/Metastatic Colorectal Cancer Trial in Guangzhou (Fruquintinib plus camrelizumab and capecitabine)

    Recruiting
    • Unresectable/Metastatic Colorectal Cancer
    • Fruquintinib plus camrelizumab and capecitabine
    • Guangzhou, Guangdong, China
      Sun Yat-sen Memorial Hospital, Sun Yat-sen University
    Nov 19, 2023

    Unresectable or Metastatic Colorectal Cancer Trial in Shenyang (FOLFOX/FOLFIRI)

    Recruiting
    • Unresectable or Metastatic Colorectal Cancer
    • Shenyang, Liaoning, China
      Liaoning Cancer Hospital & Institute
    Mar 22, 2023

    Metastatic Pancreatic Cancer Trial (FOLFIRINOX treatment)

    Not yet recruiting
    • Metastatic Pancreatic Cancer
    • FOLFIRINOX treatment
    • (no location specified)
    Aug 9, 2023

    Melanoma Trial (ABP 206, Nivolumab)

    Not yet recruiting
    • Melanoma
    • (no location specified)
    Sep 20, 2023

    Carcinoma, Intrahepatic Cholangiocarcinoma, Gallbladder Cancer Trial (HAIC, Surufatinib, Tislelizumab)

    Not yet recruiting
    • Carcinoma
    • +7 more
    • (no location specified)
    Nov 12, 2023

    Unresectable Metastatic Colorectal Cancer Trial (ABBV-400, Bevacizumab, Folinic Acid)

    Not yet recruiting
    • Unresectable Metastatic Colorectal Cancer
    • (no location specified)
    Oct 25, 2023

    Dabrafenib Plus Trametinib In Rare BRAF V600E Mutation-Positive

    Not yet recruiting
    • Rare Unresectable or Metastatic BRAF V600E Mutation-positive Solid Tumors
    • Non-investigational
    • (no location specified)
    May 11, 2023

    Pancreatic Ductal Adenocarcinoma Trial (OT-101, FOLFIRINOX)

    Not yet recruiting
    • Pancreatic Ductal Adenocarcinoma
    • (no location specified)
    Oct 5, 2023

    GIST - Gastrointestinal Stromal Tumor Trial (ripretinib)

    Approved for marketing
    • GIST - Gastrointestinal Stromal Tumor
    • (no location specified)
    May 27, 2020

    Metastatic or Unresectable Gastrointestinal Stromal Tumors

    Not yet recruiting
    • Gastrointestinal Stromal Tumors
    • +2 more
      • (no location specified)
      Jul 16, 2022

      DESTINY Breast Respond HER2-low Europe

      Not yet recruiting
      • Unresectable Breast Cancer
      • +2 more
      • Trastuzumab deruxtecan
      • (no location specified)
      Jul 6, 2023

      METAstatic Gastrointestinal Stromal Tumors (METAGIST)

      Recruiting
      • Gastro Intestinal Stromal Tumor
      • oral tyrosine-kinase inhibitors (TKI) of KIT and PDGFR as per recommendations
      • Bordeaux, France
        Institut Bergonié, Comprehensive Cancer Center
      Dec 1, 2022

      Gastrointestinal Stromal Tumor Trial in Oslo (Discontinuation of imatinib)

      Suspended
      • Gastrointestinal Stromal Tumor
      • Discontinuation of imatinib
      • Oslo, Norway
        Oslo University Hospital
      Feb 7, 2022